Literature DB >> 18287873

Preventing cancer through tobacco and infection control: how many lives can we save in the next 10 years?

Kathleen Strong1, Colin Mathers, Joanne Epping-Jordan, Serge Resnikoff, Andreas Ullrich.   

Abstract

This paper presents projections for cancer mortality, incidence and burden of disease (as disability adjusted life years) for 2005, 2015 and 2030. The projections are based on the latest available WHO mortality estimates from 2002, updated with mortality data from 107 countries and augmented by region and site-specific cancer survival models. Cancer accounted for an estimated 7.6 million deaths in 2005, and 72% of these deaths were in low-income and middle-income countries. For cancer deaths under age 70, 79% are estimated to occur in low-income and middle-income countries. Without intervention, the number of global deaths is projected to rise to 9 million in 2015 and a further 11.5 million in 2030. The rising burden of this disease, especially in low-income and middle-income countries, leads us to propose a global goal for cancer: a 2% reduction per annum over and above that which may happen as a result of current trends in prevention, case management and treatment. Achieving this goal would result in 7.7 million fewer deaths from cancer over the period from 2005 to 2015. More of these deaths will be averted in low-income and middle-income countries than in high-income countries. The scientific knowledge to achieve this goal already exists, and the target could be reached through effective cancer prevention strategies, including tobacco control, hepatitis B vaccination and prevention of cervical cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18287873     DOI: 10.1097/CEJ.0b013e3282b6fda8

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

Review 1.  Perspectives for cancer prevention with natural compounds.

Authors:  A R M Ruhul Amin; Omer Kucuk; Fadlo R Khuri; Dong M Shin
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

2.  Prediction of cancer incidence in Tyrol/Austria for year of diagnosis 2020.

Authors:  Willi Oberaigner; Sabine Geiger-Gritsch
Journal:  Wien Klin Wochenschr       Date:  2014-09-06       Impact factor: 1.704

3.  Evaluating stem and cancerous biomarkers in CD15+CD44+ KYSE30 cells.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Ahamd Reza Bahrami; Kamran Ghaffarzadegan; Hamid Cheshomi; Sara Lari; Bahram Memar; Mun Seng Kan
Journal:  Tumour Biol       Date:  2013-10

4.  Effects of High Doses of Vitamin C on Cancer Patients in Singapore: Nine Cases.

Authors:  Yuen Chuen Fong Raymond; Chong Sze Ling Glenda; Lim Kah Meng
Journal:  Integr Cancer Ther       Date:  2015-12-17       Impact factor: 3.279

5.  Bioassay-Guided Isolation and Evaluation of Antiproliferative Effects of (Z)-Ethylidene-4, 6-Dimethoxycoumaran-3-One fromzzm321990Pogostemon Quadrifolius (Benth.)

Authors:  Sanith Cheriyamundath; Rahul Raghavan; Asoke Banerji; Karel D Klika; Cornelia Ulrich; Robert W Owen; Joseph Madassery
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

6.  The landscape of viral expression and host gene fusion and adaptation in human cancer.

Authors:  Ka-Wei Tang; Babak Alaei-Mahabadi; Tore Samuelsson; Magnus Lindh; Erik Larsson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Virome assembly and annotation in brain tissue based on next-generation sequencing.

Authors:  Zihao Yuan; Xiaohua Ye; Lisha Zhu; Ningyan Zhang; Zhiqiang An; W Jim Zheng
Journal:  Cancer Med       Date:  2020-08-01       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.